Lilly To Pay Up To $690 Mil. To Settle Majority Of Zyprexa Injury Claims

Settlement will cover approximately 8,000 personal injury claims regarding diabetes and hyperglycemia, or about 75% of the total number of cases, Lilly says. “Lilly is prepared to continue its vigorous defense of Zyprexa in the remaining cases,” the company said.